Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBTEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CL.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.123.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.9.2.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EW.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.132 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-4838.81South Korea
BA.4.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KF.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.83EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDGEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.53EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EU.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HU.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JB.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.55EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HH.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FM.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EU.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.1.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCSEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used